Navigation Links
Onyx Pharmaceuticals Reports Third Quarter 2011 Financial Results
Date:11/2/2011

to regorafenib, a late-stage oncology compound. 

On a GAAP basis, Onyx reported a net loss of $36.9 million, or $0.58 per diluted share, for the third quarter 2011 compared to a net income of $41.5 million, or $0.66 per diluted share, for the same period in 2010. A description of the non-GAAP calculations and reconciliation to comparable GAAP measures is provided in the accompanying table entitled "Reconciliation of GAAP to Non-GAAP Net Income (Loss)."

Revenue from Collaboration AgreementGlobal Nexavar net sales, which are recorded by Onyx's collaborator, Bayer, were $250.3 million for the third quarter 2011, an increase of $24.1 million, or 11%, compared to $226.2 million for the same period in 2010. Onyx and Bayer are marketing and developing Nexavar® (sorafenib) tablets, an anticancer therapy currently approved for the treatment of unresectable liver cancer and advanced kidney cancer in over 100 countries worldwide.

For the third quarter 2011, Onyx reported total revenue from collaboration agreement of $75.0 million compared to $63.7 million for the same period in 2010.

License RevenueIn the third quarter 2010, Onyx recorded license revenue of $59.2 million, reflecting a fee earned as a part of the consideration under the September 2010 exclusive license agreement with Ono Pharmaceutical Co., Ltd.

Operating ExpensesOnyx recorded research and development expenses of $58.5 million in the third quarter 2011 compared to $44.6 million for the same period in 2010. The increase in research and development expense was primarily due to investments in the development of carfilzomib, particularly the Phase 3 ASPIRE and FOCUS trials as well as increased investment in the manufacturing of carfilzomib.  

Selling, general and administrative expenses were $42.6 million in the third quarter 2011, compared to $25.9 million for the same period in 2010. Higher selling, general and administrative
'/>"/>

SOURCE Onyx Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
2. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
3. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
4. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
5. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
6. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
7. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
8. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
9. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
10. Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss
11. Acura Pharmaceuticals, Inc. Secures Financing to Fund Pivotal Phase III Clinical Trial for Lead Aversion(R) Technology Product Candidate
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/18/2013)... , May 18, 2013 Although colonoscopy exams ... considered the most sensitive method for detecting colorectal cancers ... preventing cancer cases 3 . EndoChoice ® Inc. ... system significantly improves the accuracy of this procedure and ... EndoChoice will be discussing these clinical trial results and ...
(Date:5/18/2013)... , May 18, 2013 The Open ... , Occupy Psychiatry , and leading ... care, announces a social media campaign showcasing video ... psychiatric model, which focuses on pathology and illness ... with the American Psychiatric Association,s (APA) rollout of ...
(Date:5/18/2013)... May 18, 2013 Faruqi & Faruqi, ... investigating potential securities fraud at AVEO Pharmaceuticals, Inc. ... (Logo: http://photos.prnewswire.com/prnh/20120119/MM38856LOGO ) The ... executives violated federal securities laws by issuing materially ... III drug trials for Tivopath (tivozanib) (titled "TIVO-1").  ...
Breaking Medicine Technology:New Study Shows Full Spectrum Endoscopy Procedure Reduces The 'Miss Rate' of Adenomas During Colonoscopy 2New Study Shows Full Spectrum Endoscopy Procedure Reduces The 'Miss Rate' of Adenomas During Colonoscopy 3New Social Media Campaign Features Stories Of Individuals Who Rejected Psychiatric Diagnoses 2New Social Media Campaign Features Stories Of Individuals Who Rejected Psychiatric Diagnoses 3Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In AVEO Pharmaceuticals, Inc. To Contact The Firm 2
... Nov. 16, 2010 Reportlinker.com announces that a ... catalogue: Global Blood Processing Supplies ... This report analyzes the worldwide ... US$ Million by the following product segments: Blood ...
... Nov. 16, 2010 Reportlinker.com announces that a ... catalogue: Top Ten World,s Leading ... A thought-provoking report on performance, capabilities, ... the worldwide pharmaceutical market. The report is designed ...
Cached Medicine Technology:Reportlinker Adds Global Blood Processing Supplies And Equipment Industry 2Reportlinker Adds Global Blood Processing Supplies And Equipment Industry 3Reportlinker Adds Global Blood Processing Supplies And Equipment Industry 4Reportlinker Adds Global Blood Processing Supplies And Equipment Industry 5Reportlinker Adds Global Blood Processing Supplies And Equipment Industry 6Reportlinker Adds Global Blood Processing Supplies And Equipment Industry 7Reportlinker Adds Global Blood Processing Supplies And Equipment Industry 8Reportlinker Adds Global Blood Processing Supplies And Equipment Industry 9Reportlinker Adds Global Blood Processing Supplies And Equipment Industry 10Reportlinker Adds Global Blood Processing Supplies And Equipment Industry 11Reportlinker Adds Global Blood Processing Supplies And Equipment Industry 12Reportlinker Adds Global Blood Processing Supplies And Equipment Industry 13Reportlinker Adds Global Blood Processing Supplies And Equipment Industry 14Reportlinker Adds Global Blood Processing Supplies And Equipment Industry 15Reportlinker Adds Global Blood Processing Supplies And Equipment Industry 16Reportlinker Adds Global Blood Processing Supplies And Equipment Industry 17Reportlinker Adds Global Blood Processing Supplies And Equipment Industry 18Reportlinker Adds Global Blood Processing Supplies And Equipment Industry 19Reportlinker Adds Global Blood Processing Supplies And Equipment Industry 20Reportlinker Adds Global Blood Processing Supplies And Equipment Industry 21Reportlinker Adds Global Blood Processing Supplies And Equipment Industry 22Reportlinker Adds Global Blood Processing Supplies And Equipment Industry 23Reportlinker Adds Global Blood Processing Supplies And Equipment Industry 24Reportlinker Adds Global Blood Processing Supplies And Equipment Industry 25Reportlinker Adds Top Ten World's Leading Pharmaceutical Companies 2Reportlinker Adds Top Ten World's Leading Pharmaceutical Companies 3Reportlinker Adds Top Ten World's Leading Pharmaceutical Companies 4Reportlinker Adds Top Ten World's Leading Pharmaceutical Companies 5Reportlinker Adds Top Ten World's Leading Pharmaceutical Companies 6Reportlinker Adds Top Ten World's Leading Pharmaceutical Companies 7
(Date:5/18/2013)... published an original art book for iPad with tango as ... who share their creations based on the traditional music genre ... iPad . , This work gathers more than 150 ... signature idiosyncrasy and passion of tango. Such book is ... it includes a free trailer of the book for readers ...
(Date:5/18/2013)... use of a smartphone application significantly improves patients, ... presented today at Digestive Disease Week (DDW). The ... the procedure, includes dietary restrictions and requires specific ... intervals. The better the preparation, the easier it ... polyps in the colon. The study, which was ...
(Date:5/18/2013)... FL (May 18, 2013) There are significant ... commonly used to diagnose or treat gastrointestinal problems, ... (DDW). , A study by New York ... more objective testing may substantially reduce the cost ... Although GERD is believed to affect nearly 25 ...
(Date:5/18/2013)... of coffee is associated with a reduced risk ... disease, Mayo Clinic research shows. The findings were ... conference in Orlando, Fla. , PSC is ... results in inflammation and subsequent fibrosis that can ... and biliary cancer. , "While rare, PSC has ...
(Date:5/18/2013)... May 18, 2013 In a May ... Preventive Double Mastectomy After Discovering Cancer Gene,” Fox News ... procedure upon learning that she carried a gene that ... breast cancer and a 50 percent risk of ovarian ... up on May 16, 2013 with a blog post ...
Breaking Medicine News(10 mins):Health News:New Art Book for iPad: Tango Art 2Health News:New smartphone application improves colonoscopy preparation 2Health News:New research identifies practice changes to improve value and quality of GI procedures 2Health News:Angelina Jolie – Scarless Breast Augmentation Surgery 2
... opinion is very vital for cancer patients as this ... should surely be taken before undergoing// surgery. ... find out whether cancer diagnosis and treatment differed with ... elsewhere was referred to the center's tumor board for ...
... Meet organized by the city board of health on 5th ... use of Trans fat in the commercially prepared foods such ... Frieden, the health commissioner said, 'We hope that the board ... into consideration the concerns raised by 24,000 restaurateurs in New ...
... investigators are learning more about how low doses of arsenic, ... areas of the United States//, affect human physiology. In a ... Research in Toxicology, the researchers report that three different steroid ... effect and a common mechanism of arsenic on how these ...
... a global initiative to develop a vaccine against malaria,// the ... ,The objective for the ‘Malaria Vaccine Technology Roadmap’ is ... fight Malaria by the year 2015. ,Malaria ... and rightly it is one of the oldest diseases in ...
... of obesity, as a causative factor for breast cancer. It ... factor for cancer, heart disease, stroke and diabetes. Scientists have ... breast cancer. ,Latest research has indicated that having ... female hormones, the presence of which elevates the risk of ...
... to be the cause of most of kids ailments ... on// advertising to teens and children. ,Victor ... lead author of the guidelines, says "Young people view ... and increasingly are being exposed to advertising on the ...
Cached Medicine News:Health News:Cancer? Get A Second Opinion 2Health News:Low Doses Of Arsenic Have Broad Impact On Hormone Activity – Says A Researc 2Health News:Low Doses Of Arsenic Have Broad Impact On Hormone Activity – Says A Researc 3
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: